• 1
    Gadient RA, Patterson, PH. Leukemia inhibitory factor, interleukin 6, and other cytokines using the gp130 transducing receptor: roles in inflammation and injury. Stem Cells 1999; 17:127137.
  • 2
    Streetz KL, Wustefeld T, Klein C, Manns MP, Trautwein C. Mediators of inflammation and acute phase response in the liver. Cell Mol Biol 2001; 47:661673.
  • 3
    Baumann H, Prowse KR, Marinkovic S, Won KA, Jahreis GP. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann N Y Acad Sci 1989; 557:280295.
  • 4
    Cheng JG, Rodriguez CI, Stewart CL. Control of uterine receptivity and embryo implantation by steroid hormone regulation of LIF production and LIF receptor activity: towards a molecular understanding of “the window of implantation”. Rev Endocr Metab Disord 2002; 3:119126.
  • 5
    Burdon T, Smith A, Savatier P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol 2002; 12:432438.
  • 6
    Kinoshita T, Miyajima A. Cytokine regulation of liver development. Biochim Biophys Acta 2002; 592:303312.
  • 7
    Li W, Liang X, Kellendonk C, Poli V, Taub R. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 2002; 277:2841128417.
  • 8
    Grant SL, Douglas AM, Goss GA, Begley CG. Oncostatin M and leukemia inhibitory factor regulate the growth of normal human breast epithelial cells. Growth Factors 2001; 19:153162.
  • 9
    Klausen P, Pedersen L, Jurlander J, Baumann H. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. Oncogene 2000; 19:36753683.
  • 10
    Nair BC, DeVico AL, Nakamura S, Copeland TD, Chen Y, Patel A, O'Neil T, et al. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 1992; 255:14301432.
  • 11
    Douglas AM, Goss GA, Sutherland RL, Hilton DJ, Berndt MC, Nicola NA, Begley CG. Expression and function of members of the cytokine receptor superfamily on breast cancer cells. Oncogene 1997; 14:661669.
  • 12
    Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 1996; 271:3263532643.
  • 13
    Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochemical J 1998; 334:297314.
  • 14
    Kim H, Baumann H. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells. Mol Cell Biol 1999; 19:53265338.
  • 15
    Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415428.
  • 16
    Smiraglia DJ, Plass C. The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene 2002; 21:54145426.
  • 17
    Weidle UH, Grossmann A. Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment. Anticancer Res 2000; 20:14711486.
  • 18
    Feinberg AP, Cui H, Ohlsson R. DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. Semin Cancer Biol 2002; 12:389398.
  • 19
    Lee JT, Jaenisch R. The (epi)genetic control of mammalian X-chromosome inactivation. Curr Opin Genet Dev 1997; 7:274280.
  • 20
    Wolf R, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001; 293:10891093.
  • 21
    Karpf AR, Peterson PW, Rawlins JT, Dalley BK, Yang Q, Albersten H, Jones DA. Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1,2, and 3 genes in colon tumor cells. Proc Natl Acad Sci U S A 1999; 96:1400714012.
  • 22
    Aviv D, Thompson EB. Variation in tyrosine aminotransferase induction in HTC cell clones. Science 1972; 177:12011203.
  • 23
    Darlington GJ, Bernhard HP, Miller RA, Ruddle FH. Expression of liver phenotypes in cultured mouse hepatoma cells. J Natl Cancer Inst 1980; 64:809819.
  • 24
    Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980; 209:497499.
  • 25
    Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13:2983.
  • 26
    Wang Z, Melmed S. Identification of an upstream enhancer within a functional promoter of the human leukemia inhibitory factor receptor gene and its alternative promoter usage. J Biol Chem 1997; 272:2795727965.
  • 27
    Blanchard F, Kinzie E, Wang Y, Duplomb L, Godard A, Held WA, Asch BB, et al. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins. Oncogene 2002; 21:62646277.
  • 28
    Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992; 89:18271831.
  • 29
    Wang Y, Robledo O, Kinzie E, Blanchard F, Richards C, Miyajima A, Baumann H. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. J Biol Chem 2000; 275:2527325285.
  • 30
    Blanchard F, Raher S, Duplomb L, Vusio P, Pitard V, Taupin JL, Moreau JF, et al. The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor. J Biol Chem 1998; 273:2088620893.
  • 31
    Baumann H. Electrophoretic analysis of acute phase plasma proteins. Methods Enzymol 1988; 163:566594.
  • 32
    Hatada I, Hayashizaki Y, Hirotsune S, Komatsubara H, Mukai TA. Genomic scanning method for higher organisms using restriction sites as lanmarks. Proc Natl Acad Sci U S A 1991; 88:95239527.
  • 33
    Antequera F, Bird A. Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci U S A 1993; 90:1199511999.
  • 34
    Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Roberson GP, Gao X, Wright FA, et al. Aberrant CpG island methylation has non-random and tumor type-specific patterns. Nat Genet 2000; 25:132138.
  • 35
    Blanchard F, Duplomb L, Wang Y, Robledo O, Kinzie E, Pitard V, Godard A, et al. Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J Biol Chem 2000; 275:2879328801.
  • 36
    Aikawa J, Ikeda-Naiki S, Ohgane J, Min KS, Imamura T, Sasai K, Shiota K, et al. Molecular cloning of rat leukemia inhibitory factor receptor α-chain gene and its expression during pregnancy. Biochim Biophys Acta 1997; 1353:266276.
  • 37
    Ware CB, Horowitz MC, Renshaw BR, Hunt JS, Liggitt D, Koblar SA, Gliniak BC, et al. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 1995; 121:12831299.
  • 38
    Antequera F, Boyes J, Bird A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 1990; 62:503514.
  • 39
    Smiraglia DJ, Rush LJ, Fruhwald MC, Dai Z, Held WA, Costello JF, Lang JC, et al. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 2001; 10:14131419.
  • 40
    Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31:141149.
  • 41
    Wade PA, Pruss D, Wolffe AP. Histone acetylation: chromatin in action. TIBS 1997; 22:128132.
  • 42
    Ng HH, Bird A. DNA methylation and chromatin modification. Curr Opin Genet Dev 1999; 9:158163.
  • 43
    Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, et al. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 2001; 28:2935.